LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - TriSalus Life Sciences (NASDAQ: TLSI)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TLSI TriSalus Life Sciences
Patience David / officer: Chief Financial Officer
08/14/2025
Buy
$3.88
290,000
$1.125M
290,000